集中带量采购政策下山东省调脂药物临床综合评价专家共识
x

请在关注微信后,向客服人员索取文件

篇名: 集中带量采购政策下山东省调脂药物临床综合评价专家共识
TITLE: CHINA PH ARMACY Volume 33,Number 15,August 15,2022 Semimonthly Table of Contents Expert consensus on the comprehensive clinical evaluation of lipid-lowering drugs under the centralized drug volume-based procurement policy in Shandong Province
摘要: 药物临床综合评价是促进药品回归临床价值的重要技术工具。在集中带量采购常态化制度化开展的背景下,积极组织开展药物临床综合评价工作至关重要。截至2022年3月,已纳入国家和山东省集中带量采购的调脂药物共有5个。为积极推动医疗机构规范开展调脂药物的临床综合评价,由山东第一医科大学附属省立医院牵头,以山东省医院协会为依托,山东省19家三级甲等医院共同参与,运用德尔菲法,通过3轮专家意见调查及广泛讨论,制定了《集中带量采购政策下山东省调脂药物临床综合评价专家共识》。该共识采用百分制量化评估,从药学特性、有效性、安全性、经济性、适宜性、可及性、创新性、其他属性共8个维度,对山东省集中带量采购涉及的15个调脂药物进行了临床综合评价,并根据分值形成不同的推荐级别。本共识的制定将有助于医疗机构在集中带量采购背景下合理配备和使用调脂药物,从而更好地满足国家政策需求,不断提高药事服务质量。
ABSTRACT: Comprehensive clinical evaluation of drugs is an important technical tool to promote the return of drugs to clinical value. Under the background of normalization and institutionalization of centralized drug volume-based procurement ,it is very crucial to actively organize and carry out comprehensive clinical evaluation of drugs. As of March 2022,there are 5 lipid-lowing drugs that have been included in the centralized drug volume-based procurement of the state and Shandong Province. In order to actively promote the medical institutions to develop the comprehensive clinical evaluation of lipid-lowing drugs standardly ,led by the Shandong Provincial Hospital Affiliated to Shandong First Medical University ,supported by Shandong Hospital Association ,and 19 third grade class A hospitals in Shandong Province jointly participated ,Using Delphi method ,through three rounds of expert opinion investigation and extensive discussion ,Expert Consensus on the Comprehensive Clinical Evaluation of Lipid-lowering Drugs under the Centralized Drug Volume-based Procurement Policy in Shandong Province was developed. The expert consensus adopted the percentage system for quantitative evaluation. The comprehensive clinical evaluation on 15 lipid-lowing drugs involved in centralized drug volume-based procurement in Shandong Province was implemented from eight dimensions including pharmaceutical characteristics ,effectiveness,safety,economy,suitability,accessibility,innovation and other attributes ,and different recommendation levels were formed according to the scores. The development of this consensus will help medical institutions to reasonably allocate and use lipid-lowering drugs in the context of centralized drug volume-based procurement ,so as to better satisfy the national policy needs and continuously improve the quality of pharmaceutical services.
期刊: 2022年第33卷第15期
作者: 山东省医院协会药物经济学专业委员会
AUTHORS: Pharmacoeconomics Committee of Shandong Hospital Association
关键字: 集中带量采购;山东省;调脂药物;临床综合评价;专家共识
KEYWORDS: centralized drug volume-based procurement ;Shandong Province ;lipid-lowering drugs ;comprehensive clinical
阅读数: 470 次
本月下载数: 45 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!